Digital Health Europe

Europe Obesity Management Apps Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Europe Obesity Management Apps Market Industry Trends and Forecast to 2034: Segmented by (Type, Revenue Model, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Europe · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $536.5 Mn Placeholder estimate
Estimate 2025 $611.0 Mn 16.5% of the global market
Projected 2034 $1.97 Bn 222.6% Adds $1.36 Bn over 9 forecast years
CAGR 2025–2034 13.9% Faster than 49% of 100 Digital Health markets here
Key players 6 +1
  • Europe is 16.5% of the global market.
  • Among regions, the largest is North America at $1.82 Bn.
  • Fastest growing: APAC at 16.2% a year.
  • Europe ranks 3rd of 6 by size among regions.

Market size projection

Europe

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$1.36 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Obesity Management Apps Market market size by year, Europe
YearMarket sizeChange that yearSince 2025
2024 (estimate) $536.5 Mn — —
2025 (base) $611.0 Mn +$74.6 Mn —
2026 (forecast) $696.0 Mn +$84.9 Mn +13.9%
2027 (forecast) $792.7 Mn +$96.7 Mn +29.7%
2028 (forecast) $902.9 Mn +$110.2 Mn +47.8%
2029 (forecast) $1.03 Bn +$125.5 Mn +68.3%
2030 (forecast) $1.17 Bn +$142.9 Mn +91.7%
2031 (forecast) $1.33 Bn +$162.8 Mn +118.3%
2032 (forecast) $1.52 Bn +$185.4 Mn +148.7%
2033 (forecast) $1.73 Bn +$211.2 Mn +183.3%
2034 (forecast) $1.97 Bn +$240.6 Mn +222.6%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Europe Obesity Management Apps Market Analysis at a glance
Market size, 2025$611.0 Mn placeholder estimate
Forecast, 2034$1.97 Bn placeholder estimate
Growth (CAGR), 2025–203413.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsType, revenue model and end user (see all)
Key playersNoom, WeightWatchers, Found, Omada Health, Lark Health and 1 more (see all)
Regulator in EuropeEU MDRSource: European Commission, medical devices. Checked 14 Nov 2026.
Active clinical trials468 in EuropeSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Europe. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Europe Obesity Management Apps Market Analysis Executive Summary

Obesity management apps support weight loss with meal tracking, coaching, medication support and links to clinicians.

Key segments of the obesity Management Apps market include type (Coaching Apps, Medication Support Platforms and Calorie and Food Trackers) and revenue model (Subscription and Employer and Payer Paid).

Bar chart: Europe Obesity Management Apps market size, 2024–2034, placeholder estimates. $536.5 Mn in 2024, $611.0 Mn in 2025 and $1.97 Bn in 2034, 13.9% CAGR.
Europe Obesity Management Apps market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Europe Obesity Management Apps Market Dynamics

Market Growth Drivers

Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the obesity Management Apps market. Wider insurance coverage and more doctors trained in obesity care are adding to demand.

Opportunity

Oral formulations, combination therapies and use in heart, kidney and liver disease open new growth paths for the obesity Management Apps market, especially in fast-growing emerging economies.

Market Restraints

High treatment prices, limited reimbursement, supply shortages and side effects that lead some patients to stop treatment hold back the obesity Management Apps market. Long-term safety data and lifestyle support are still needed for many patients.

Competitive Landscape for Obesity Management Apps Market in Europe

The obesity Management Apps market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Obesity Management Apps Market in Europe

Obesity Management Apps in Europe: rules, payment and research

Under the EU Medical Device Regulation (MDR), software used for diagnosis or treatment counts as a medical device.⁠[1] In some of the countries we cover here, rules for health software come from EU MDR and ANSM (France)⁠[1], BfArM (DiGA) (Germany)⁠[2], EU MDR and Ministry of Health (Italy)⁠[1], EU MDR and AEMPS (Spain)⁠[1] and MHRA (UK)⁠[3]. Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines.⁠[4] ClinicalTrials.gov lists 468 studies on Obesity Management Apps that are recruiting, active or about to start in Europe.⁠[5]

[1] European Commission, medical devices. Checked 14 Nov 2026.

[2] BfArM DiGA directory. Checked 14 Nov 2026.

[3] Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.

[4] European Commission, health technology assessment. Checked 14 Nov 2026.

[5] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Europe. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the obesity Management Apps market. Government digital health programs in Europe are speeding up adoption.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Obesity Management Apps right now, from free public sources.

Clinical trials

468 active trials in UK, Germany, France, Italy, Spain, Netherlands, Belgium, Switzerland, Sweden, Denmark, Poland, Turkey and Russia

Recruiting, about to start, or running now. Counted across the 13 countries we report on in Europe.

Top trial sponsors (worldwide)

  1. Eli Lilly and Company 60 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Novo Nordisk A/S 59 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Pfizer Inc. 20 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Amgen Inc. 18 active trials on ClinicalTrials.gov (opens in a new tab)
  5. AstraZeneca 13 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Patients

Obesity (adults), % of adults (WHO)
CountryValueYear
Belgium20.82024
Denmark14.32024
France11.22024
Germany20.62024
Italy14.02024
Netherlands14.72024
Poland21.82024
Russia17.62024
Spain15.32024
Sweden17.52024
Switzerland11.32024
Turkey28.82024
UK27.42024
Compare every country on the Public Health Dashboard

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory. Fetched 20 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Obesity Management Apps in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Obesity Management Apps market in Europe?
Placeholder estimate: about $611.0 Mn in 2025, rising to about $1.97 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Obesity Management Apps market in Europe growing?
Placeholder estimate: about 13.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Obesity Management Apps market report cover?
The report splits the market by type (Coaching Apps, Medication Support Platforms, Calorie and Food Trackers), revenue model (Subscription, Employer and Payer Paid) and end user (Healthcare Providers, Patients, Payers, Pharmaceutical Companies).
Who are the key players in the Obesity Management Apps market?
Key players include Noom, WeightWatchers, Found, Omada Health, Lark Health and MyFitnessPal.
What is driving the Obesity Management Apps market?
Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the obesity Management Apps market.
Who regulates Obesity Management Apps in Europe?
Under the EU Medical Device Regulation (MDR), software used for diagnosis or treatment counts as a medical device. Source: European Commission, medical devices. Checked 14 Nov 2026.
How is healthcare paid for in Europe?
Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines. Source: European Commission, health technology assessment. Checked 14 Nov 2026.
How many clinical trials on Obesity Management Apps are running in Europe?
468 studies are recruiting, active or about to start in Europe, counted across the 13 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Europe. Retrieved 12 Nov 2026.
How much research is published on Obesity Management Apps?
PubMed lists 70 papers on Obesity Management Apps added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Digital Health reports in Europe

See all

Related on obesity and digital health

See the topic